scPharmaceuticals Inc. (SCPH) Financials
Stock symbol SCPH is outdated, potentially delisted? Maybe it is available on other exchange?
SCPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 80.3 million | 101.6 million |
| March 31, 2025 | 91.0 million | 96.1 million |
| Dec. 31, 2024 | 107.5 million | 94.2 million |
| Sept. 30, 2024 | 125.1 million | 94.4 million |
SCPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | -16.1 million | 1.5 million |
| March 31, 2025 | -17.1 million | 1.3 million |
| Dec. 31, 2024 | -15.2 million | 1.3 million |
| Sept. 30, 2024 | -17.4 million | 1.2 million |
SCPH Net Income
No data available :(
SCPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 40.8 million | 53.2 million | 984000 |
| March 31, 2025 | 57.5 million | 52.1 million | 1.3 million |
| Dec. 31, 2024 | 75.7 million | 52.5 million | 1.3 million |
| Sept. 30, 2024 | 91.5 million | 52.3 million | 1.4 million |
SCPH Shares Outstanding
SCPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | - | 4.1 million | 21.2 million | - |
| March 31, 2025 | - | 4.6 million | 21.4 million | - |
| Dec. 31, 2024 | 12000 | 3.2 million | 21.4 million | - |
| Sept. 30, 2024 | 9000 | 3.5 million | 21.3 million | - |
SCPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | 16.0 million | 5.0 million |
| March 31, 2025 | 11.8 million | 3.5 million |
| Dec. 31, 2024 | 12.2 million | 4.0 million |
| Sept. 30, 2024 | 10.0 million | 3.3 million |
SCPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SCPH
Price: $5.67
52 week price:
Earnings Per Share: -1.81 USD
P/E Ratio: -3.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 152000
Market Capitalization: 302.2 million